EFFECT OF GOVERNMENT AND COMMERCIAL WARNINGS ON REDUCING PRESCRIPTION MISUSE - THE CASE OF PROPOXYPHENE

被引：66

作者：

SOUMERAI, SB ^{[1
]}

AVORN, J ^{[1
]}

GORTMAKER, S ^{[1
]}

HAWLEY, S ^{[1
]}

机构：

[1] HARVARD UNIV,SCH PUBL HLTH,DEPT BEHAV SCI,BOSTON,MA 02115

来源：

关键词：

D O I：

10.2105/AJPH.77.12.1518

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：1518 / 1523

页数：6

共 59 条

[1] *AM MED ASS, 1980, AMA DRUG EV, P214
[2] [Anonymous], 1975, PHARM TIMES, V41, P39
[3] [Anonymous], 1979, PHARM TIMES, V45, P29
[4] [Anonymous], 1984, PHARM TIMES, V50, P27
[5] [Anonymous], 1976, PHARM TIMES, V42, P37
[6] [Anonymous], 1974, PHARM TIMES, V40, P35
[7] *APPL MAN SCI, 1974, 2 DRUG B SURV
[8] IMPROVING DRUG-THERAPY DECISIONS THROUGH EDUCATIONAL OUTREACH - A RANDOMIZED CONTROLLED TRIAL OF ACADEMICALLY BASED DETAILING
AVORN, J
SOUMERAI, SB
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (24) : 1457 - 1463
[9] SCIENTIFIC VERSUS COMMERCIAL SOURCES OF INFLUENCE ON THE PRESCRIBING BEHAVIOR OF PHYSICIANS
AVORN, J
CHEN, M
HARTLEY, R
[J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (01) : 4 - 8
[10] BAUM C, 1987, PUBLIC HEALTH REP, V102, P426